IRCT20200105046010N106尚未招募Unknown
In-vivo Bioequivalence Study of Metformin 500 mg FC. Tablets of The Test Drug ( Sajjad Darou, Iran) in Compared with The Reference Drug (GLUCOPHAGE® 500 mg. Merck Serono, Germany) In Iranian Healthy Volunteers
Sajad darou shargh0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28) kg/m^2
- •Age (18-55 years old)
- •Informed consent
排除标准
- •Nicotine consumption
- •history Cardiovascular disease
- •History Liver and kidney
- •Alcohol and opioid addiction
- •Allergy reactions history to metformin
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Metformin 500mg tablet (Zagross Darou Pharma)IRCT20200105046010N36Zagross Darou Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of Metformin 500 mg ( VARIOMET® 500 mg) manufactured by Faran pharmedThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200105046010N98Faran Pharmed company24
已完成
不适用
Bio equivalence study of metformin 500 mgIRCT20200513047423N1Sana Med24
尚未招募
Unknown
Bioequivalence study of Metformin 500mg tabletIRCT20200623047902N27Ronak Pharm company36
尚未招募
Unknown
Bioequivalence study of Metformin 1000 mg E.R. Tablet in 24 healthy male under fasting conditionsIRCT20180620040164N67Dorsa Pharmaceutical Co.24